large granular lymphocytic leukemia | Drugs Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

20,296 results for “large granular lymphocytic leukemia”

anti-CD3/CD19 bispecific antibody, (acute lymphocytic leukemia)

anti-CD19 CAR T-cell therapy (Chronic lymphocytic leukemia)

Oncoquest-CLL

Chronic lymphocytic leukaemia vaccine (MaxCyte)

anti-CD19 CAR T-cell therapy (acute lymphoblastic leukemia/diffuse large B cell lymphoma)

dual anti-CD19/anti-CD20 CAR T-cells (chronic lymphocytic leukemia/B-cell lymphomas)

Cytarabine(Cytosar, Vyxeos, Vyxeos liposomal (previously Vyxeos))

Manufacturer: Pacira pharmaceuticals inc, App pharmaceuticals llc +3 more

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia +7 more

C₉H₁₃N₃O₅ · Rx

Venetoclax(Venclexta, Venclyxto)

Conditions: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia +1 more

C₄₅H₅₀ClN₇O₇S · Rx

MALT-1 inhibitors (diffuse large B-cell lymphoma)

MLLT1/3 inhibitors (acute lymphoblastic leukemia/acute myelogenous leukemia)

Page 1 of 65